Global Immunoprecipitation Market 2019-2024 by Product (Kit, Reagent (Antibodies, Magnetic Buffer)), Type (Individual IP, Coimmunoprecipitation, CHIP)

News provided by

Feb 20, 2019, 14:45 ET

DUBLIN, Feb. 20, 2019 /PRNewswire/ -- The "Immunoprecipitation Market by Product (Kit, Reagent (Antibodies, Magnetic Buffer)), Type (Individual IP, Coimmunoprecipitation, CHIP), End User (Academics, Research Institutes, Pharmaceutical and Biotechnology Companies) - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.

Increasing research activity in the life sciences industry is expected to drive the overall growth of the immunoprecipitation market.

The immunoprecipitation market is projected to reach USD 750 million by 2024 from USD 560 million in 2018, at CAGR of 5.0% during forecast period.

The growth of this market is majorly driven by the increasing number of research activities in the life sciences industry and the growing need to identify antigens associated with autoimmune diseases (through antigen-antibody interaction to understand disease mechanisms and develop relevant drugs targeting these diseases). However, the presence of alternative technologies for protein purification is expected to restrain the growth of this market in the coming years.

The kits segment is expected to grow at the highest CAGR during the forecast period.

The immunoprecipitation market, by product, has been categorized into three major segments - kits, reagents, and accessories. The kits segment is estimated to grow at the highest CAGR from 2018 to 2024. The need for repeat purchase of kits, coupled with the increasing number of IP assays to isolate and purify antigens, forms a major driver for the growth of this segment.

The pharmaceutical & biotechnology companies segment is expected to grow at the highest CAGR during the forecast period.

The immunoprecipitation market, by end user, has been categorized into three major segments - academic & research institutes, pharmaceutical & biotechnology companies, and contract research organizations (CROs). The pharmaceutical & biotechnology companies segment is estimated to grow at the highest CAGR from 2018 to 2024. The increasing demand for protein-based drugs to drive the demand for immunoprecipitation in this end-user segment will support market growth.

Asia Pacific projected to grow at the highest CAGR during the forecast period.

In the immunoprecipitation market, Asia Pacific is projected to record the highest growth during the forecast period. China, Japan, and India are the major markets for immunoprecipitation in the Asia Pacific. Increasing investments by governments and industries, growing biotechnology research in these regions, and rising awareness about personalized therapeutics are expected to drive the growth of these markets during the forecast period.

The immunoprecipitation market comprises major providers such as Thermo Fisher Scientific (US), Abcam (UK), Merck KGaA (Germany).

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Immunoprecipitation: Market Overview
4.2 Immunoprecipitation Market, By Product (2018-2024)
4.3 North America: Immunoprecipitation Market, By Type (2018)

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Increasing Number of Life Sciences Research Activities
5.2.1.2 Growing Need to Identify Antigens That are Associated With Autoimmune Diseases
5.2.2 Restraints
5.2.2.1 Presence of Alternative Technologies
5.2.3 Opportunities
5.2.3.1 Increasing Focus on Biomarker Discovery
5.2.4 Challenges
5.2.4.1 Quality Concerns Over Research Antibodies

6 Immunoprecipitation Market, By Type
6.1 Introduction
6.2 Individual Immunoprecipitation
6.2.1 Increasing Demand for Biologics is Driving the Growth of the Market
6.3 Co-Immunoprecipitation
6.3.1 Increasing Use of Co-Ip to Study Protein Complexes Forms A Key Market Driver
6.4 Chromatin Immunoprecipitation
6.4.1 Growing Adoption of High-Throughput Technologies Will Contribute to Adoption of Chip
6.5 Rna Immunoprecipitation
6.5.1 Availability of Government Funding Will Drive the Adoption of Rip Kits

7 Immunoprecipitation Market, By Product
7.1 Introduction
7.2 Kits
7.2.1 Kits Segment to Account for the Largest Share of the Immunoprecipitation Market During the Forecast Period
7.3 Reagents
7.3.1 Antibodies
7.3.1.1 Antibodies, By Type
7.3.1.1.1 Primary Antibodies
7.3.1.1.1.1 Primary Antibodies to Account for the Largest Share of the Immunoprecipitation Antibodies Market During the Forecast Period
7.3.1.1.2 Secondary Antibodies
7.3.1.1.2.1 Low Cost of Production - A Major Factor Driving the Growth of the Secondary Antibodies Market
7.3.2 Beads
7.3.2.1 Beads, By Type
7.3.2.2 Agarose Beads
7.3.2.2.1 High Binding Capacity and Lower Cost - Factors Supporting the Wide Use of Agarose Beads in Research Laboratories
7.3.2.3 Magnetic Beads
7.3.2.3.1 Magnetic Bead-Based Separation Helps Increase Throughput and Reduces Hands-On Time
7.3.2.4 Buffers
7.3.2.4.1 Buffer Solutions Play an Important Role in Maintaining Ph Balance in Ip Assays
7.4 Accessories

8 Immunoprecipitation Market, By End User
8.1 Introduction
8.2 Academic & Research Institutes
8.2.1 Academic & Research Institutes are the Largest End Users of Immunoprecipitation
8.3 Pharmaceutical & Biotechnology Companies
8.3.1 Increasing Demand for Protein-Based Drugs to Drive the Demand for Immunoprecipitation in This End-User Segment
8.4 Contract Research Organizations
8.4.1 Growth in Outsourcing of Protein Purification Activities - A Major Factor Driving the Demand for Immunoprecipitation Technologies in Contract Research Organizations

9 Immunoprecipitation Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 Growing Research Will Drive Market Growth
9.2.2 Canada
9.2.2.1 Increasing Genomics and Proteomics Research to Drive the Adoption of Immunoprecipitation in the Coming Years
9.3 Europe
9.3.1 Growth of the Life Sciences Sector Will Support the Demand for Immunoprecipitation
9.4 Asia Pacific
9.4.1 Increasing Demand for Novel Antibody and Protein-Based Drugs Support Market Growth in the Asia Pacific
9.5 Rest of the World

10 Competitive Landscape
10.1 Overview
10.2 Vendor Benchmarking
10.3 Competitive Leadership Mapping
10.3.1 Visionary Leaders
10.3.2 Innovators
10.3.3 Dynamic Differentiators
10.3.4 Emerging Companies
10.4 Market Ranking Analysis, 2017
10.5 Competitive Situation and Trends
10.5.1 Expansions
10.5.2 Collaborations, Partnerships, and Agreements
10.5.3 Product Launches
10.5.4 Acquisitions

11 Company Profiles
11.1 Thermo Fisher Scientific
11.2 Abcam
11.3 Genscript
11.4 Merck KGaA
11.5 Bio-Rad Laboratories
11.6 Biolegend
11.7 Takara Bio
11.8 Rockland Immunochemicals
11.9 Cell Signaling Technology
11.10 Geno Technology

For more information about this report visit https://www.researchandmarkets.com/research/cs9ssc/global?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets